Publication | Closed Access

In vitro human plasma distribution of nanoparticulate paclitaxel is dependent on the physicochemical properties of poly(ethylene glycol)-block-poly(caprolactone) nanoparticles

NanoparticlesNanomedicineEthylene GlycolEngineeringPolymer-drug ConjugateTherapeutic NanomaterialsPharmaceutical NanotechnologyNano-drug DeliveryBiomedical EngineeringPharmacologyNanoparticulate PaclitaxelPhysicochemical Properties